Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03032666 |
|
Recruitment Status :
Completed
First Posted : January 26, 2017
Last Update Posted : October 11, 2018
|
Sponsor:
Ala'a Sharara
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Ala'a Sharara, American University of Beirut Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | August 6, 2018 |
| Actual Study Completion Date : | August 6, 2018 |